Pulled From EU Assessment Process: Orphan Drugs For Kidney Disease, Mesothelioma

 
• By Ian Schofield
  
Lung radiography
An orphan drug for mesothelioma is one of two products withdrawn from the CHMPassessment process

More from Product Reviews

More from Pink Sheet